Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Finland,Belgium,Italy,Hungary,Denmark,France,Germany,Netherlands,Switzerland,Portugal
Trial Manager
Update Il y a 5 ans
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
To assess the efficacy of two different treatment regimens of etanercept in psoriasis subjects with psoriatic arthritis with respect to both the skin and joint manifestations.
Country
Argentina
,
Australia
,
Austria
,
Belgium
,
Czech Republic
,
Denmark
,
Finland
,
France
,
Germany
,
Greece
,
Hungary
,
Italy
,
Korea, Republic of
,
Mexico
,
Netherlands
,
Poland
,
Portugal
,
Saudi Arabia
,
Serbia
,
Spain
,
Sweden
,
Switzerland
,
Taiwan, Province of China
,
Turkey
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
This study will assess the efficacy and safety of nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive/BCR-ABL positive chronic myeloid leukaemia in chronic phase. The aim of the study is to confirm the rates of complete molecular remission (CMR) of nilotinib in newly diagnosed CML chronic phase patients in a pan-European population using the EUTOS standardized laboratories.
Country
Austria
,
Belgium
,
Bulgaria
,
Croatia
,
Czech Republic
,
Denmark
,
Estonia
,
Finland
,
France
,
Germany
,
Greece
,
Hungary
,
Italy
,
Latvia
,
Lithuania
,
Netherlands
,
Norway
,
Poland
,
Portugal
,
Romania
,
Slovakia
,
Slovenia
,
Spain
,
Sweden
,
Switzerland
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).
Country
Australia
,
Austria
,
Belgium
,
Canada
,
China
,
Czech Republic
,
Denmark
,
Finland
,
France
,
Germany
,
Greece
,
Hungary
,
Israel
,
Italy
,
Latvia
,
Lithuania
,
Netherlands
,
New Zealand
,
Philippines
,
Poland
,
Portugal
,
Russian Federation
,
Singapore
,
South Africa
,
Spain
,
Switzerland
,
Taiwan, Province of China
,
Thailand
,
Turkey
,
Ukraine
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1